Industry Experts – Market Research Reports

Industry Experts caters the market research needs of a broad range of industry verticals comprising Automotive, Healthcare, Food & Beverage, Telecom & Internet, Chemicals & Plastics, Biotechnology and Consumer Goods. The company also provides customized market research and industry analysis services for a wide range of industry sectors.

15 Jul

Biopharmaceuticals Global Market to Grow by Robust 13.5% (2010-2020) to Reach $498 Billion by 2020

Posted in Biotechnology, News on 15.07.13 by IE Admin

Industry Experts, a multi industry focused market research firm, has unveiled the 2013 version of ‘Biopharmaceuticals – A Global Market Overview’. As per the new report monoclonal antibodies (moAb) constitutes the largest product segment in the global biopharmaceuticals market accounting for an estimated share of 25.6% in 2013, equating to US$51.1 billion. In addition, monoclonal antibodies (moAb) are forecasted to record fastest growth in reaching US$138.8 billion by 2020 at a 2010-20 CAGR of 14.9%.
The pharmaceutical R&D pipeline and industry have been witnessing greater degree of dependence on biopharmaceuticals. Development of these products is being undertaken by a growing number of players in the pharmaceutical industry, which include the big pharma companies as also generic drug manufacturers, who are also engaged in developing biosimilars. In conjunction with the traditional small biopharmaceutical companies, the new bigger entrants have been focused on continually expanding the global biologics pipeline, implying that the number and proportion of new pharmaceuticals being commercialized would increasingly comprise biopharmaceuticals and not small molecule drugs. As the cost of developing biopharmaceuticals and bringing them to market is generally much higher, offering enhanced profit margins, it comes as no surprise that the global pharmaceutical industry would continue to rely on biopharmaceuticals for profits and innovation, in addition to its very survival.
Even though the worldwide economic recession has been slow in recovering, the global pharmaceutical and biopharmaceutical industries have marched ahead, showing profitability and growth. According to estimates, more than 10k therapeutics are currently in the research and development stage, which include chemical substance pharmaceuticals or drugs and biotechnology-derived pharmaceuticals or biopharmaceuticals undergoing over 40k clinical trials. This translates into a significant increase from as little as half-a-decade back, indicating a conspicuous shift in the pharmaceutical industry from developing small molecule drugs to biopharmaceuticals for obtaining novel, ground-breaking and profitable solutions.
The report reviews, analyses and projects the biopharmaceuticals market (2010-2020) for global and the regional markets including North America, Europe, Asia-Pacific, South America and Rest of World. The regional markets further analyzed for 14 independent countries across North America – The United States, Canada and Mexico; Europe – Germany, the United Kingdom, France, Italy, Spain and Russia; Asia-Pacific – Japan, China and India; South America – Argentina and Brazil.
Biopharmaceuticals product segments analyzed in this study comprises Monoclonal Antibodies (moAb), Erythropoietin, Biotech Vaccines, Recombinant Human (RH) Insulin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and others. Therapeutic areas analyzed include Neurology, Infectious Diseases, Diabetes, Oncology, Cardiovascular and others. Biopharmaceuticals market, estimated at US$199.7 billion globally in 2013, is further projected to reach US$497.9 billion by 2020, growing at 13.5% CAGR between 2010 and 2020. Among different product segments, monoclonal antibodies (moAb) constitutes the largest product segment in the global biopharmaceuticals market accounting for an estimated share of 25.6% in 2013, equating to US$51.1 billion. In terms of therapeutic area, neurology applications is the largest market for global biopharmaceuticals with an estimated 2013 share of 28.2% valued at US$56.3 billion, and further expected reach a projected US$144.5 billion by 2020.
The study includes 249 charts (includes a data table and graphical representation for each chart), supported with meaningful and easy to understand graphical presentation, of market numbers. The statistical tables represent the data for the global market by geographic region, product segment and therapeutic area. This study profiles 25 key global players and 70 major players across North America – 24; Europe – 17; Asia-Pacific – 27 and Rest of World – 2. The report also provides the listing of the companies engaged in research and development, manufacturing and supply of biopharmaceuticals. The global list of companies covers addresses, contact numbers and the website addresses of 492 companies.

For more details, please visit http://industry-experts.com/verticals/biotechnology/biopharmaceuticals-a-global-market-overview.html

tags: , , , , , ,

56 Comments »

08 Jul

Global Synthetic Vitamin-E Market to Touch $1600 Million by 2020

Posted in General Reports, News on 08.07.13 by IE Admin

Industry Experts, a multi industry focused market research firm, has today announced the availability an exclusive a research report on Synthetic Vitamin E market. The new report ‘Synthetic Vitamin E – A Global Market Overview’ reveals that the global consumption of synthetic vitamin E, in terms of volume stood at 100.3 thousand metric tons valued at US$1.06 million in 2012, is further expected to maintain a volume CAGR of 4.2% between 2012 and 2020 to reach a projected 139.1 thousand metric tons in 2020, while value CAGR is anticipated to be 5.2% over the same period that would enable in boosting up demand for synthetic vitamin E to US$1.6 billion in 2020.

An increasing demand for livestock directly translates into increasing demand for animal feed and animal feed additives such as vitamins. Synthetic vitamin E is the key ingredient used in global animal feed industry today. It is obvious that demand for synthetic vitamin E for animal feed applications would continue to grow as demand for livestock also grows, more so in the developing regions of Asia, Africa and Latin America. Countries, such as Brazil, China, Russia and other Asian and African regions have been on a catching up mode as they are increasingly adopting modern animal production systems to keep abreast of enhancing domestic demand.

Animal feed is the largest application area with a volume share of about 81.9%, translating into 82.1 thousand metric tons, and value share of 67.1% equating to US$712.9 million in 2012. Further, consumption of synthetic vitamin E by the animal feed industry is also expected to record the fastest 2012-2020 CAGR of 4.5% in reaching a projected 116.5 thousand metric tons in 2020 in terms volume and projected to reach US$1.1 billion by 2020 at a CAGR of 5.7% over 2012-2020 in terms of value.

The synthetic vitamin E growth in animal feed industry is mainly attributed to the animal feed industry’s growth in developing world. The demand for livestock products such as meat, poultry etc. is increasing rapidly in developing nations. The main attributes for this growth would be population growth, urbanization and especially growing household incomes in these countries. General patterns of food consumption and specific demand for livestock products are greatly shaped by levels of urbanization and growth in income. As a consequence, these developing nations are the regions slated to emerge as the fastest growing for food products derived from livestock.

The report reviews, analyses and projects the synthetic vitamin E market for global and the regional markets including North America, Europe, Asia-Pacific and Rest of World. The regional markets further analyzed for independent countries across North America – The United States, Canada and Mexico; Europe – Germany, France, Italy, Spain, The United Kingdom, The Netherlands and Rest of Europe; Asia-Pacific – China, Japan and Rest of Asia-Pacific. Synthetic vitamin E end-use applications covered in this report include animal feed, dietary supplements, food & beverages and cosmetics.

The study includes 95 charts (includes a data table and graphical representation for each chart), supported with meaningful and easy to understand graphical presentation, of market numbers. The statistical tables represent the data for the global synthetic vitamin E market value in metric tons and value in US$ by geographic region and end-use application. This study profiles 6 key global players and 15 major players across Europe – 3; Asia-Pacific – 11 and Rest of World – 1. The report also provides the listing of the companies engaged in the manufacturing and supply of synthetic vitamin E as well as major players in vitamin E end-use industries such as human nutrition, animal nutrition and personal care. The global list of companies covers addresses, contact numbers and the website addresses of 107 companies.

For more details, please visit http://industry-experts.com/verticals/general/synthetic-vitamin-E-a-global-market-overview.html

tags: , , , , ,

50 Comments »

28 May

Global Medical Imaging Devices Market to Grow by 7% CAGR to reach $49 billion by 2020

Posted in Healthcare, News on 28.05.13 by IE Admin

Industry Experts, a multi industry focused market research firm, has today announced the availability of 2013 version of the market research report ‘Medical Imaging Devices – A Global Market Overview’. The new report reveals that the global market for medical imaging devices is estimated at US$30.2 billion in 2013. The X-Ray remains the largest imaging modality while CT, Ultrasound and MRI to follow closely during the analysis period 2010-2020.

The medical imaging device industry has been evolving ever since its inception, with assurance of cost and clinical advantages offered furthering access to a range of imaging modalities in several medical applications. Demographics, such as an aging population pool, constitute a key factor in bolstering market growth, though device manufacturers are faced with the prospect of providing innovative and patient-friendly solutions that support enhanced safety and ease of operation.

Global trends have suggested a marked shift from the saturated North American and European markets to the more lucrative regions constituting the emerging economies of Asia-Pacific, Latin America and Central & Eastern Europe. For instance, the increasing prevalence of cardiovascular diseases has ensued in swelling demand for imaging modalities comprising equipment and software solutions in the critical clinical area. This has further underscored the requirement for technologically advanced medical imaging modalities, though uptake levels have been adversely impacted because of incongruity in deciding the imaging modality most appropriate for a specific cardiac disorder.

The major product segments of medical imaging devices analyzed in this study include Computer Tomography (CT), Magnetic Resonance Imaging (MRI), Positron Emission Tomography (PET), Ultrasound, X-Ray, Nuclear Imaging and PACS. Global market for Medical Imaging Devices is projected to exceed US$49 billion by 2020 from an estimated US$30.2 billion in 2013.

The report reviews, analyses and projects the Medical Imaging Devices market for global and the regional markets including the United States, Canada, Japan, Europe, Asia-Pacific and Rest of World. The regional markets further analyzed for 10 independent countries across Europe – France, Germany, Italy, Spain, the United Kingdom and Rest of Europe; and Asia-Pacific – China, India, South Korea, Australia, Taiwan and Rest of Asia-Pacific.

This 298 page, global market report comprises 93 charts (includes a data table and graphical representation for each chart), supported with meaningful and easy to understand graphical presentation, of market numbers. The statistical tables represent the data for the global market value in USD by geographic regions and product segment of medical imaging devices. This report profiles 39 key global players and 50 major players across the United States – 32; Canada – 2; Japan – 4; Europe – 8; Asia-Pacific – 3 and Rest of World – 1. The report also provides the listing of the companies engaged in research, technology development, manufacturing and the supply of medical imaging devices. The global list of companies covers addresses, contact numbers and the website addresses of 495 companies.

For more details, please visit: http://industry-experts.com/verticals/healthcare/medical-imaging-devices-a-global-market-overview.html

tags: , , , , , , , , , ,

40 Comments »

14 Jan

Global Carbon Fibers Market to touch 141k MTs by 2020 while Composites to reach 210k MTs

Posted in News on 14.01.13 by IE Admin

Industry Experts, a multi industry focused market research firm, has today added a new market research report ‘Carbon Fibers & Carbon Fiber Reinforced Plastics (CFRP) – A Global Market Overview’ to its Chemicals & Plastics catalogue. According to the new report, the global market for Carbon Fibers and Carbon Fiber Composites is mainly driven by the wind energy, aerospcae & Defense and Sports & Leisure sectors which are estimated to consume 11.3k MTs, 9.4k MTs and 8.3k MTs by the year 2013.
Carbon fibers have gained an immense importance in a range of applications in industrial sectors such as wind energy, automotive, civil engineering, pressure vessels as well as in aerospace & military, motorsports and other sporting goods because of their superior characteristics like enhanced stiffness & tensile strength, low weight, improved chemical resistance & temperature tolerance and low thermal expansion. The industries, having the high growth potential for carbon fiber reinforced plastics (CFRP) and intern carbon fibers in the near future include automotive, wind energy, aerospace & defense, offshore oil & gas applications and composite pressure vessels among others.
The study reviews, analyzes and projects the global market for Carbon Fibers and Carbon Fiber Reinforced Plastics (CFRP) for the period 2008-2020 while discussing the global Carbon Fiber installed capacities. The report also focuses on current market trends and future strategies of the industry.
Market for Carbon Fibers and Carbon Fiber Reinforced Plastics application areas analyzed in the study include aerospace & defense, sporting goods & leisure and industrial applications such as automotive, wind energy, pressure vessels, construction & infrastructure, compounds for electrical/electronic applications, oil & gas applications and others. Further, the report estimates and projects the global market for both carbon fiber reinforced plastics and carbon fibers for the period 2008-2020, in terms of volume (metric tons) as well as value (US$ million) by geographic regions including North America, Europe, Japan, Asia and Rest of World.
Global volume demand for CFRP, estimated at around 67 thousand metric tons in 2012, is expected to maintain a 2012-2020 CAGR of 15.3% to reach 210 thousand metric tons by 2020. In terms of value, demand for CFRP, estimated at US$10.25 billion in 2012 is expected to record a CAGR of 11.9% over 2012-2020 in reaching US$25.2 billion by 2020. In tandem with the CFRP market, global demand for carbon fibers in terms of volume, estimated at 45 thousand metric tons in 2012 and forecast to be 51.7 thousand metric tons in 2013, is further projected to reach 141 thousand metric tons by 2020, registering a 2012-2020 CAGR of 15.4%. In terms of value, consumption of carbon fibers globally is estimated to stand at US$2.03 billion in 2012 and projected to reach around US$5 billion by 2020.
This 507 pages, global market report includes 146 charts (includes a data table and graphical representation for each chart), supported with meaningful and easy to understand graphical presentation, of the market. The statistical tables represent the data for the global market by geographic region and end-use applications of Carbon Fibers. Data tables for production capacities are illustrated by precursor type, geographic region, country and by major manufacturer. The brief business profiles of 74 key global players comprising 27 Carbon Fiber, 6 Recycle Carbon Fiber and 41 Carbon Fiber Composite manufacturers. The report includes the listing of 54 companies that are engaged manufacturing of carbon fibers, recycled carbon fibers, carbon fiber precursors and low-cost carbon fiber research and development. The study also provides Carbon Fiber Composites global list of 209 players encompasses the companies that are engaged in manufacturing, supplying, molding and fabricating the carbon fiber composites.

For more details, please visit http://industry-experts.com/verticals/chemicalsandplastics/carbon-fibers-and-carbon-fiber-reinforced-plastics-a-global-market-overview.html

tags: , , , ,

49 Comments »

08 Oct

Global Medical Nutrition Market to Reach $29 billion in 2013

Posted in Healthcare, News on 08.10.12 by IE Admin

Hyderabad, 08 Oct 2012 – Industry Experts, a multi industry focused market research firm, announces availability of the new global market report ‘Medical Nutrition – A Global Market Overview’.

An increase in aging populations coupled with growing incidences of illnesses and a condition requiring medical nutrition products has resulted in market growth for medical nutrition products. Another key factor that driving the market is premature births because of insufficient nutrition supply to mothers, especially in Asia, in most populous countries such as China and India. However, medical nutrition products that contain probiotics and prebiotics, primarily targeted at the aging population, are witnessing unprecedented demand as against traditional medical nutrition products, opening the gates for a new market dominated by very few players.

Medical Nutrition product segments analyzed in this study include Infant, Enteral and Parenteral. The report also analyses the sub-segments of Enteral Medical Nutrition comprising Standardized, Elemental/Semi-Elemental and Specialized Entetal Nutrition. The global market for Medical Nutrition, estimated at US$27.2 billion in 2012 and forecast to be US$28.8 billion in 2013, is further projected to reach US$40.1 billion by 2018, thereby exhibiting a 2008-2018 CAGR of 5.8%.

The report reviews and analyses the worldwide market for medical nutrition products for the global and the regional markets including North America, Europe, Asia-Pacific, South America and Rest of World. The regional markets further analyzed for 15 independent countries across North America – the United States, Canada and Mexico; Europe – Germany, France, the United Kingdom, Italy, Spain and Rest of Europe; Asia-Pacific – Japan, China, India, South Korea and Rest of Asia-Pacific; South America – Brazil, Argentina and Rest of South America.

This 387 page global market report includes 180 rich data tables, supported with meaningful and easy to understand graphical presentation, of market numbers. The statistical tables represent the data for the medical nutrition global market value by geographic regions, product segments/sub-segments. This market report covers the brief business profiles of 25 key global players and 46 major players across North America – 28; Europe – 12; and Asia-Pacific – 6. The report also provides the listing of the companies that are engaged in manufacturing, research and development, processing, supplies and distribution of Medical Nutrition products. This global list includes the addresses, contact numbers and the website addresses of 220 companies.

For more details, please visit http://industry-experts.com/verticals/healthcare/medical-nutrition-a-global-market-overview.html

tags: , ,

61 Comments »